APA (7th ed.) Citation

Kolodziejczak, A. S., Selt, F., Peterziel, H., Jamaladdin, N., Mack, N., Maaß, K. K., . . . Milde, T. (2026). Preclinical drug screen identifies WEE1 inhibitor and vinca alkaloid as a combination treatment concept for Li-Fraumeni syndrome medulloblastoma. iScience, 29(2), . https://doi.org/10.1016/j.isci.2025.114564

Chicago Style (17th ed.) Citation

Kolodziejczak, Anna S., et al. "Preclinical Drug Screen Identifies WEE1 Inhibitor and Vinca Alkaloid as a Combination Treatment Concept for Li-Fraumeni Syndrome Medulloblastoma." IScience 29, no. 2 (2026). https://doi.org/10.1016/j.isci.2025.114564.

MLA (9th ed.) Citation

Kolodziejczak, Anna S., et al. "Preclinical Drug Screen Identifies WEE1 Inhibitor and Vinca Alkaloid as a Combination Treatment Concept for Li-Fraumeni Syndrome Medulloblastoma." IScience, vol. 29, no. 2, 2026, https://doi.org/10.1016/j.isci.2025.114564.